Entera Bio
ENTX
5 hedge funds and large institutions have $2.62M invested in Entera Bio in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0.5% less ownership
Funds ownership: 9.3% → 8.8% (-0.5%)
17% less funds holding
Funds holding: 6 → 5 (-1)
25% less capital invested
Capital invested by funds: $3.49M → $2.62M (-$868K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
-$28.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 3 |
DAM
DLD Asset Management
New York
|
-$1.26K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$633 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $1.18M | – | – | – |
|
|
DAM
2
DLD Asset Management
New York
| $919K | -$1.26K | -442 | -0.1% |
|
|
WCM
3
Wildcat Capital Management
New York
| $481K | -$28.5K | -10,000 | -5% |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $39K | +$1.26K | +442 | +3% |
|
|
5
UBS Group
Zurich,
Switzerland
| $1K | -$633 | -222 | -32% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$3K | -862 | Closed |
|
ENTX Hedge Fund Activity: Q3 2019 in Review
5 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2019, worth a combined $2.62M — down 25% from $3.49M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ENTX and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Worth Venture Partners, adding an estimated $1.26K. The largest seller was Wildcat Capital Management, cutting an estimated $28.5K.
- 5 institutional investors held Entera Bio (ENTX) as of Q3 2019, down from 6 in Q2 2019.
- Funds reported $2.62M of Entera Bio stock for Q3 2019, down 25% quarter-over-quarter.
- 0 funds opened new Entera Bio positions in Q3 2019 and 1 closed out, a net change of -1 holder.
- The largest Entera Bio buyer in Q3 2019 was Worth Venture Partners, an estimated $1.26K added.
- The largest Entera Bio seller in Q3 2019 was Wildcat Capital Management, an estimated $28.5K sold.
Based on aggregated 13F filings for Q3 2019.